Home/Filings/4/0001437749-22-008211
4//SEC Filing

DARGAN CHARLES K 4

Accession 0001437749-22-008211

CIK 0000880242other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:11 PM ET

Size

13.9 KB

Accession

0001437749-22-008211

Insider Transaction Report

Form 4
Period: 2022-03-31
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option to purchase common stock

    2022-03-31+127,5004,086,500 total
    Exercise: $0.23From: 2022-03-31Exp: 2032-03-31Common stock (127,500 underlying)
Footnotes (1)
  • [F1]This Option was granted to Reporting Person to replace option(s) previously issued in lieu of cash compensation to Reporting Person for services provided to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price of the Option and the current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001112799

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:11 PM ET
Size
13.9 KB